mTOR also modulates cardiac fibrosis in the models of post-MI remodeling and cardiac hypertrophy [70, 101, 102] while treatment with rapamycin reduced ROS production in the myofibroblasts. This evidence concerns the gene MTOR and myocardial infarction.